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Background/Aim. Overweight/obesity has become important 
health problem in developed countries. It may be related to a 
presence of low-grade inflammation in white adipose tissue. The 
aim of this study was to investigate the levels of inflammatory 
marker C-reactive protein (CRP) and its relation to anthropomet-
ric parameters in overweight and obese females. Methods. This 
study included 200 apparently healthy, overweight and obese 
women (18–45 years). Their standard and alternative anthro-
pometric parameters [body mass index (BMI), percentage of fat 
(%F), waist circumference (WC), waist-to-hip ratio (WHR), 
waist-to-height ratio (WHtR), body adiposity index (BAI)] were 
determined and correlated to serum CRP concentration. Re-
sults. Average CRP level was 5.56 ± 2.43 mg/L, and it signifi-
cantly positively correlated to all investigated anthropometric pa-
rameters. There was significant difference between overweight 
and obese group in all investigated anthropometric parameters, 
as well as in CRP values. When investigated separately, according 
to BMI, values regarding obese females showed significant corre-
lation between CRP and every investigated anthropometric pa-
rameter. In overweight subjects, no such correlation was re-
corded. In the obese group, all investigated parameters were sig-
nificantly related to F. In overweight subjects, body weight (BW), 
BMI, WC and WHtR showed significant relation to F. Conclu-
sion. The significant difference between the overweight and 
obese group in all parameters of central obesity was found as 
well as in the CRP levels. In the obese group, we found strong 
correlation between adiposity measured by fat percentage and 
parameters of central obesity, while in the overweight group 
WHR and BAI did not correlate to fat percentage. Our results 
confirmed that CRP is a valuable marker of metabolic risk in 
obese females, and BMI, although not so new, is still reliable pa-
rameter of adiposity.  
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Uvod/Cilj. Prekomerna telesna masa i gojaznost postali su 
značajan zdravstveni problem u razvijenim zemljama, a mogu 
biti povezani sa prisustvom hronične inflamacije niskog 
intenziteta u belom masnom tkivu. Cilj rada bio je da se ispitaju 
nivoi markera inflamacije, C-reaktivnog proteina (CRP), i 
njegova povezanost sa standardnim antropometrijskim 
parametrima kod predgojaznih i gojaznih žena. Metode. 
Studijom je bilo obuhvaćeno 200 zdravih žena (18–45 god) 
kojima su određeni standardni i alternativni antropometrijski 
parametari [indeks telesne mase (BMI), procenat masti (%F), 
obim struka (WC), odnos obima struka i kukova (WHR), 
odnos obima struka i visine (WHtR), kao i indeks telesne 
masnoće (BAI)] koji su zatim korelisani sa koncentracijama 
CRP u serumu. Rezultati. Prosečna vrednost nivoa CRP u 
serumu u celoj grupi iznosila je 5,56 ± 2,43 mg/L i utvrđena je 
njegova značajna pozitivna korelacija  sa svim ispitivanim an-
tropometrijskim parametrima. Uočena je statistički značajna 
razlika između grupa predgojaznih i gojaznih žena u svim 
ispitivanim antropometrijskim parametrima, kao i u pogledu 
koncentracije CRP. U grupi gojaznih ispitanica utvrđena je 
značajna povezanost između CRP i svih antropometrijskih pa-
rametara, dok u predgojaznoj grupi nije zabeležena statistička 
značajnost. U grupi gojaznih, svi antropometrijski pokazatelji 
pokazali su značajnu korelaciju sa procentom telesne masti, a 
kod predgojaznih žena, korelacija je bila značajna samo za tele-
snu masu, BMI, WC i WHtR. Zaključak. Između 
predgojaznih i gojaznih ispitanica postoji značajna razlika u 
pogledu svih pokazatelja centralne gojaznosti, kao i u pogledu 
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koncentacije CRP u serumu. U grupi gojaznih, pokazana je 
značajna korelacija između sadržaja masti, izraženog kao 
procenat masnoće, i svih pokazatelja visceralne distribucije 
masti, dok u grupi predgojaznih značajna povezanost nije 
urađena za WHR и BAI. Naši rezultati potvrđuju da CRP 
može predstavljati značajan marker metaboličkog rizika kod 
gojaznih žena, kao i da je BMI, iako spada u tradicionalne 
parametre, i dalje pouzdan pokazatelj sadržaja telesne masti. 
Ključne reči: 
gojaznost; telesna masa, prekomerna; žene; 
antropometrija; c-reaktivni protein. 
Introduction 
Overweight/obesity has become important health prob-
lem in developed countries. It may be related to presence of 
low-grade inflammation in white adipose tissue 1. Precise 
mechanisms of chronic inflammation induction in obesity as 
well as the relation between obesity and inflammatory mar-
kers are yet to be explained 1, 2. So far, the importance of C-
reactive protein (CRP), as the most versatile inflammatory 
marker, is still in the spotlight.  
CRP is acute-phase protein and inflammatory marker. 
Increased concentrations of CRP are present in serum after 
tissue injury, infection and inflammation 3. Its synthesis takes 
place in liver, and is mostly regulated by interleukin-6 (IL-
6). Numerous surveys classified CRP as important marker of 
inflammation, which may indicate early vascular lesions, and 
may be a predictor of cardiovascular events, even in 
apparently healthy population 4. Most of the studies confirm 
that even levels below the accepted upper physiological li-
mits (1 mg/dL) may indicate the increased risk of heart and 
cerebral stoke, peripheral atherosclerosis, and sudden death 
in both gender 1, 5, 6. CRP outstands as independent risk fac-
tor, apparent from traditional risk factors such as increased 
total cholesterol, increased levels of glucose and 
homocystein, hypertension, age, high body mass index 
(BMI), smoking and physical inactivity 7.  
In general, recent studies indicate that white adipose tis-
sue produces numerous mediators, for example, cytokines 
tumor necrosis factor alpha (TNFα) and IL-6. In addition, in 
obese persons, white adipose tissue is infiltrated by macrop-
hages with increased local production of proinflammatory 
mediators. These factors promote acute phase reaction and 
chronic inflammation in obese persons 4. 
However, some authors proposed the existence of a 
subgroup of obese persons who are metabolically normal 
(without increased risks of heart diseases, type 2 diabetes, 
hypertension, stroke, gallbladder disease, cancers, etc.) 8. 
They hypothesize that in this subpopulation obesity seems to 
be uncomplicated and is characterized by early onset, hyper-
plasticity of otherwise normal adipocytes, and peripheral 
type of fat distribution. The inflammation in these persons 
should be absent, and they supposed to have normal levels of 
inflammatory markers. 
The aim of this study was is to investigate the levels of 
inflammatory marker CRP and its relation to standard anthro-
pometric parameters [body mass (BM), BMI, percentage of fat 
(F), waist circumference (WC), waist-to-hip ratio (WHR), 
waist-to-height ratio (WHtR)], as well as to alternative para-
meter, the body adiposity index (BAI), in population of 
apparently healthy overweight and obese females.  
Methods 
This study enrolled 103 overweight (BMI between 25 and 
29.9 kg/m2) and 97 obese (BMI ≥ 30 kg/m2) females, nonsmo-
kers, aged 18–45 years, without any comorbidities, and with re-
gular menstrual cycles. Our study did not include persons with: 
clinically confirmed hypertension, glucose intolerance or diabe-
tes, other endocrine or systemic inflammatory diseases, cardio-
vascular and/or cerebrovascular diseases, malignant diseases, 
pregnancy, and those with CRP values higher than 10 mg/L at 
the moment of investigation. None of them had previous history 
of stroke, transitory ischemic attack, angina pectoris, heart stro-
ke, or congenital heart abnormality. At the moment of investiga-
tion, they did not take any medical drugs, supplements, oral con-
traceptives, or hormonal substitution drugs. Investigation was 
approved by the local Ethical Committee and was conducted in 
Department of Nutrition, Institute of Hygiene, Military Medical 
Academy, Belgrade, Serbia, during 2013 and 2014.  
Standard anthropometric measurements were performed: 
body weight (BW), body height, WC and hip circumference 9, 
skinfold thickness, and followed parameters were calculated: 
BMI [kg/m2], percentage of fat (%F) 10, waist-to-hip ratio 
(WHR), waist-to-height ratio (WHtR) 9, and BAI [hip circumfe-
rence (cm)/height 1, 5 (m) – 18] 11. High sensitive CRP was mea-
sured in serum using enzymatic kits (Roche Diagnostics, Basel, 
Switzerland) on a Siemens autoanalyser (Dimension®, RxL 
Max, Siemens Dade Behring). Concentrations lower than 1 
mg/L refer to low risk for cardiovascular diseases, values 
between 1 and 3 mg/L were in an average range, and values 
higher than 3 mg/L were considered as high risk 6. WC less than 
80 cm considered normal, between 80 and 87.9 cm referred to 
increased risk of metabolic complications, and ≥ 88 cm referred 
to substantially increased risk 9; WHR ≥ 0.8 was also considered 
increased, as well as WHtR ≥ 0.62 12. 
Obtained data were statistically processed and presen-
ted as means ± SD; some of the data were presented as pro-
portions (%). Difference between groups and correlation 
between chosen parameters and CRP values were analyzed 
by Student’s t-test (χ2 test for categories) and Spearman’s 
rank correlation (r), respectively. Statistical significance was 
accepted at p < 0.05. 
Results 
Anthropometric parameters and serum concentrations 
of CRP in all 200 investigated subjects together are pre-
sented in Table 1. 
Average CRP was 5.56 ± 2.43 mg/L, and significantly 
positively correlated to all investigated anthropometric pa-
rameters (BW: r = 0.3329, p < 0.01; BMI: 0.3567, p < 0.01; 
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Table 1 
Anthropometric parameters and C-reactive protein (CRP) values of the study subjects 
Parameters ґ ± SD min–max 
Age (year) 31.12 ± 7.26 18–45 
BW (kg) 87.99 ± 14.99 60.60–144.00 
BMI (kg/m2) 31.16 ± 5.08 25.04–51.24 
%F 41.04 ± 4.98 28.70–56.00 
WC (cm) 95.75 ± 12.98 70.00–148.00 
WHR 0.85 ± 0.08 0.65–1.12 
WHtR 0.57 ± 0.08 0.43–0.87 
BAI 33.93 ± 4.99 23.06–50.40 
CRP (mg/L) 5.56 ± 2.42 0.82–10.00 
BW – body weight; BMI – body mass index; %F – fat percentage; WC – waist 
circumference; WHR – waist-to-hip ratio; WHtR – waist-to-height ratio; BAI – body 
adiposity index; CRP – C-reactive protein. 
ґ – mean value; SD – standard deviation. 
 
Table 2 
Anthropometric parameters and C-reactive protein (CRP)  
values in overweight and obese groups of women 
Overweight Obese Parameter ґ ± SD p ґ ± SD 
Age (years) 31.55 ± 7.66 30.69 ± 7.60 n.s. 
BW (kg) 77.82 ± 6.89 98.80 ± 13.67 < 0.000 
BMI (kg/m2) 27.49 ± 1.35 35.05 ± 4.67 < 0.000 
%F 38.23 ± 3.26 44.03 ± 4.75 < 0.000 
WC (cm) 88.13 ± 6.94 103.84 ± 13.03 < 0.000 
WHR 0.83 ± 0.07 0.87 ± 0.08 0.0011 
WHtR 0.52 ± 0.04 0.62 ± 0.08 < 0.000 
BAI  30.86 ± 2.55 37.19 ± 4.89 < 0.000 
CRP (mg/L) 4.95 ± 2.29 6.21 ± 2.41 0.0002 
 For abbreviations see under Table 1. 
 
 
Table 3  
Spearman’s correlation coefficient (r) in overweight and obese women 
Correlation to CRP, (r; p) Correlation to %F; (r; p) Parameter overweight obese  overweight obese 
Age  -0.1225; n.s. -0.0525; n.s. -0.1152; n.s. 0.0843; n.s. 
BW  0.0625; n.s. 0.3101; < 0.01 0.2000; < 0.05 0.6077; < 0.01 
BMI  0.1927; n.s. 0.3103; < 0.01 0.4664; < 0.01 0.6179; < 0.01 
WC 0.1206; n.s. 0.3628; < 0.001 0.3679; < 0.01 0.6366; < 0.01 
WHR 0.0935; n.s. 0.2831; < 0.001 0.1693; n.s. 0.4566; < 0.01 
WHtR 0.1493; n.s. 0.3455; < 0.001 0.4081; < 0.01 0.6096; < 0.01 
BAI  0.0749; n.s. 0.2806; < 0.01 0.0749; n.s. 0.3776; < 0.01 
F -0.064; n.s. 0.2757; < 0.001   
CRP   -0.064; n.s. 0.2757; < 0.001 
%F: 0.2589, p < 0.01; WC: 0.3645, p < 0.01; WHR: 0.2417, 
p < 0.01; WHtR: 0.3637, p < 0.01, and BAI: 0.2063, 
p < 0.05). 
Statistical analysis showed the significant difference 
between the overweight and obese group for all investigated 
anthropometric parameters, except for the age as well as 
CRP values (Table 2).  
Moreover, when the overweight and obese groups were 
presented separately, according to BMI, the different correla-
tion between anthropometric parameters and CRP values 
were found. The results are presented in Table 3. 
In both groups, there was no statistically significant cor-
relation between CRP levels and age. In addition, in over-
weight subjects, no significant correlation was recorded be-
tween CRP and any anthropometric measurement or index 
whatsoever. On the other hand, in the obese group, every in-
vestigated anthropometric parameter was significantly corre-
lated to CRP levels. 
Percentage of fat measures body adiposity. In both gro-
ups, age was not significantly correlated to this parameter. In 
the overweight subjects, neither WHR nor BAI showed sig-
nificant relation to %F, opposite to BW, BMI, WC and 
WHtR. In the obese group, all investigated parameters were 
significantly related to %F.  
 n.s. – non significant. 
 For abbreviations see under Table 1. 
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According to BMI, all subjects were overweight or obe-
se. However, fat distribution was different: in the overweight 
group, 10 (9.7%) women had normal values of WC, in 52 
(50.5%) women the recorded values were in the range of inc-
reased risk of metabolic complications and in 41 (39.8%) 
women substantially increased risk values were recorded. In 
the obese group, there was only 1 person with normal WC, 5 
with values suggesting increased risk, and 91 (93.8%) with 
substantially increased risk. These differences were 
statistically significant (p < 0.05). When risk is estimated ac-
cording to WHR, there were 37 (35.9%) subjects in the 
overweight group with normal WHR, and 66 (64.1%) with 
increased WHR. In the obese group, normal WHR was re-
corded in 17 (17.5%) subjects and increased WHR in 80 
(82.5%). In the overweight group, all subjects had normal 
WHtR, while in the obese group 33 (34%) of them had inc-
reased risk, i.e. WHtR ≥ 0.62 (p < 0.05).  
In addition, 2 persons in the overweight group had CRP 
concentration in the range of low risk, 15 persons in the ran-
ge of average, and 86 (83.5%) in the range of high risk of 
cardiovascular disease development. In the obese group, inc-
reased values of CRP were recorded in 93 (95.9%) subjects, 
with 4 persons in average range and no subject in low risk 
range, but these differences were not statistically significant.  
Discussion 
Obesity is extensively spread disease, which is, due to its 
metabolic effects, considered the most frequent risk factor for 
development of diabetes, hypertension and atherosclerosis. 
However, obesity itself, when defined according to body mass, 
is less powerful predictor comparing to central obesity, so re-
cently anthropometric parameters have been adopted in order 
to achieve better discrimination of body adiposity and meta-
bolic risk. The accuracy and usefulness of numerous parame-
ters were analyzed, such as WC, WHR, WHtR 12, and BAI 11. 
The important difference between men and women re-
garding body fat storage is considering the fact that women 
have more adipocytes at the start of their adult life (hyper-
plastic obesity), so they may accumulate more fat compared 
to men 13. Later, process of fat accumulation is particularly 
rapid in subcutaneous abdominal area as the result of adipo-
cyte hypertrophy. These observations served as foundations 
for suggestions that, especially in young women, obesity 
without comorbidities might be present. In our study, all 
women were apparently healthy and relatively young (18–45 
years). However, the average levels of CRP were elevated in 
both groups, particularly in the obese one, and the difference 
between groups was statistically significant. 
Despite the absence of metabolic diseases, according to 
our results, average WC of all investigated subjects was 
95.55 ± 12.98 cm, and WHR 0.85 ± 0.08, suggesting high 
frequency of visceral obesity, and increased risk of metabolic 
complications. However, when observed as WHtR ratio, vis-
ceral obesity was less pronounced: mean value was 
0.57 ± 0.08, which is bellow the accepted limit of increased 
risk (0.62). In the overweight group, we found 90% of 
women with increased or substantially increased values of 
WC, but all subjects in this group were in the normal range 
of WHtR. In the obese group, we found that almost every 
woman  had increased WC, but only one-third was in the 
range of increased metabolic risk when categorized accor-
ding to WHtR. WC was significantly related to increased risk 
of hypertension even in young (22–30 years) student popula-
tion in Serbia 14. 
To date, the investigations were directed to obese or 
morbid obese men and women. Studies performed on over-
weight persons are sparse. Considering the frequency of 
overweight persons in our population, and the possibility of 
prediction the cardiovascular risk regardless of age and ac-
tual health status, we wanted to investigate this problem in 
particular. 
The major characteristic of our results is significant dif-
ference observed between overweight and obese subjects in 
almost all important features. Besides the anthropometric dif-
ferences which were expected (BW, BMI, %F), in the 
overweight group we recorded significantly lower values of 
parameters that reflect the metabolic risk: WC, WHR, 
WHtR, as well as significantly lower values of inflammatory 
marker CRP. CRP is a strong predictor of future vascular 
events, and the value obtained from initial blood sample may 
be useful in prediction even after twenty years 6. When 
analyzed several large studies conducted both in Europe and 
the USA,  the same author found the strong relationship 
between CRP concentrations and future cardiovascular 
events, apart from other risk factors. Prospective random 
study from MONICA project has processed large sample of 
initially health middle aged population and indicated the sa-
me strong relationship 5. Moreover, the results from this 
study demonstrated that obese persons showed two-fold hig-
her concentrations of CRP compared to persons with normal 
BMI. The importance of central obesity is confirmed in nu-
merous studies, which proved stronger correlation of WC 
and WHR to higher cardiovascular risk, compared to BMI 14. 
The role of visceral obesity is particularly important in per-
sons with normal BMI.  
The results from the Women’s Health Study which en-
rolled 39,876 middle-aged women showed that women with 
CRP levels higher than 75th percentile (> 0.59 mg/dL) also 
had higher BMI, WC and WHR. After adjusting for age, 
CRP demonstrated strong correlation with BMI and W, but 
less strong correlation with WHR 15. The results of our inves-
tigation confirmed the strong correlation between CRP levels 
and parameters of central adiposity in obese women, but also 
with BMI. This association is absent in overweight females. 
A meta-analysis of 10 studies with a total of 88,514 
subjects concluded that discriminatory power of markers of 
central obesity, such as WHtR, regarding cardiovascular risk 
is better than BMI, but this difference is small, insignificant, 
and with no clinical relevance 12. Our results confirmed that 
WHtR significantly correlated with overall fat percentage, 
both in the overweight and obese group, but the correlation 
between WHtR and CRP was present only in the obese 
group. 
The same pattern is observed for BAI. In this study we 
also estimated BAI as a new parameter of body adiposity, 
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which is very simple for use, since it does not require weight 
measurement. It is calculated from body height and hip cir-
cumference 11 and can be used to reflect overall fat (visceral 
and subcutaneous) percentage in both sexes and in different 
ethnicity. Although in mentioned large study conducted by 
Bergman et al. 11, BAI was defined as a strong predictor of 
fat percentage, our result showed significant correlation 
between these two parameters only in obese women, and not 
in overweight ones. In general, in the obese group we found 
that all anthropometric parameters and indices (BW, BMI, 
WC, WHR, WHtR and BAI) were significantly correlated to 
%F and hence reflect the overall adiposity.  
Central obesity is strongly related to metabolic risk and 
has been identified as a useful predictor of metabolic syn-
drome. The link that connects visceral obesity to its meta-
bolic complications may be systemic insulin resistance, how-
ever, the influence of adipose tissue on insulin sensitivity is 
not clear enough. Chronic inflammation is common charac-
teristic of metabolic syndrome, particularly related to insulin 
resistance. On the other hand, infection and inflammation are 
also related to insulin resistance, while visceral obesity is re-
lated to chronic low-grade inflammation. Hence, these ob-
servations may introduce inflammation as a possible mecha-
nism of effects of obesity on insulin resistance. 
The proposed mechanism of induction of inflammation 
in obesity is increased secretory activity in adipose tissue. 
Adipose tissue is the site of production of numerous 
secretory factors (adipokines), with pro- and anti-
inflammatory effects 16–18. Homeostasis is maintained due to 
the balance in secretion of different factors. This homeostasis 
may be impaired in presence of adipose tissue enlargement, 
resulting in dysregulation of adipokine production, and 
following local and/or systemic inflammatory reaction 19. 
Excessive fat tissue produces proinflammatory factors, 
particularly TNFα and IL-6, but also generates acute-phase 
reactants such as plasminogen activator inhibitor-1 (PAI-1), 
haptoglobin, serum amyloid A, which are the major contribu-
tors of low-grade systemic inflammation 20. Obese persons 
seem to have increased activation of kinases in adipose tis-
sue, and subsequently increased expression of inflammatory 
cytokines 21. Levels of inflammatory cytokines in obese men 
and women are higher than in non-obese ones, and might be 
related to insulin resistance 22. TNFα and other pro-
inflammatory cytokines can contribute to inhibition of insu-
lin receptor stubstrate-1 by inducing serine phosphorylation. 
Enlarged adipose tissue in humans also leads to infiltration 
of inflammatory immune cells and macrophages with sub-
stantial loss of functional programming, which may promote 
inflammation 23, 24. 
These inflammatory mediators then induce synthesis of 
acute-phase reactants in liver, among them CRP, which is 
induced largely by IL-6. This results in increased serum con-
centration of these molecules even in healthy obese persons 25, 
including children 26. These observations are in agreement 
with our results. 
In order to explore this suggested association, Pannac-
ciulli et al. 3 investigated CRP levels in apparently healthy 
women of different age (18–60 years), and with different nu-
tritional status (normal weight, overweight, and obese) in re-
lation to body composition and fat distribution. They found 
that CRP concentrations are correlated to fat mass, regardless 
of age, but visceral adiposity (measured by WC) was stron-
ger predictor of CRP compared to overall fat mass. In additi-
on, another study performed in 119 young (20–40 years) and 
healthy obese adults of both sexes showed that fat mass and 
fat percentage were predictors of CRP levels in a group of 
females under 30 years, but body composition did not predict 
CRP neither in older females, nor in males of any age 27. 
Conclusion 
In population of apparently healthy relatively young 
women, we found significant difference between the over-
weight and obese group in all parameters of central obesity, 
as well as in CRP levels. However, we recorded elevated 
concentrations of CRP even in overweight women. CRP lev-
els were positively correlated to BMI, WC, WHR, WHtR, 
BAI and in the obese group, regardless of age, but in the 
overweight group no correlation was recorded. Finally, in the 
obese group, we found strong correlation between adiposity 
measured by fat percentage and parameters of central obe-
sity, while in the overweight group WHR and BAI did not 
correlate to fat percentage. Our results confirmed that CRP is 
a valuable marker of metabolic risk in obese females, and 
BMI, although not so new, is still a reliable parameter of 
adiposity. 
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